January 11, 2026

Cell map unlocks secrets of how reproductive organs form

Cell map unlocks secrets of how reproductive organs form

A new single-cell map reveals how human reproductive organs form and respond to environmental influences

A developing human reproductive tract stained for marker of the Wolffian duct (cyan) and markers of the regressing Mullerian Duct (yellow and magenta). Credit: Cecilia Icoresi Mazzeo, Staff Scientist/Wellcome Sanger Institute

New research has mapped the cell types that specialise to form reproductive organs in both sexes, identifying key genes and signals that drive this process. The findings offer important insights into conditions affecting the reproductive organs and how environmental chemicals may affect reproductive health.

Researchers at EMBL’s European Bioinformatics Institute (EMBL-EBI) and the Wellcome Sanger Institute used a combination of single-cell and spatial genomics technologies to analyse over half a million human cells from the developing reproductive system. 

This study, published in the journal Nature, provides the most detailed picture to date of how reproductive organs form in the womb, uncovering crucial biological pathways that shape their development.

“For the first time, we can see in detail how the human reproductive system is assembled before birth,” said Valentina Lorenzi, Staff Scientist at the Wellcome Sanger Institute and former PhD student at EMBL-EBI in the Marioni Group. “This map pinpoints the exact cells and signals that shape each organ, and highlights when development is most vulnerable. This is an essential step towards understanding fertility, congenital alterations, and the impact of our environment on reproductive health.”

How does human sex differentiation occur?

Although chromosomal sex (XX or XY) is determined at conception, visible differences in the developing reproductive system do not appear until about six weeks later. At this stage, all embryos have undifferentiated gonads as well as the same paired structures – the Müllerian ducts and the Wolffian ducts – which have the potential to form the female or male internal reproductive organs.

A gene on the Y chromosome called SRY triggers the undifferentiated gonads to develop into the testes; the testes then produce hormones that guide the Wolffian ducts to form male reproductive structures and cause the Müllerian ducts to regress. In the absence of SRY, the gonads become ovaries, and the Müllerian ducts develop into female reproductive organs.

Mapping reproductive development 

While development of the gonads has been mapped at the cellular and molecular level in detail due to their importance in fertility, the development of the rest of the reproductive system has been far less understood, until now. 

In this study, researchers analysed over half a million individual cells from 89 donated embryonic and fetal tissue samples, to look at what genes and signals underpin the differentiation of the male and female reproductive tract. The study is part of the Human Cell Atlas initiative, which is mapping all cell types in the body to understand health and disease.

“Many conditions affecting fertility and reproductive health have their roots in development before birth, yet until now we lacked a full picture of how these organs form in humans,” said Roser Vento-Tormo, Group leader at the Wellcome Sanger Institute. “Our atlas offers that missing piece, providing a powerful resource for both basic science and clinical research.”

This press release was adapted from the full press release published on the Wellcome Sanger website. 

Funding

This research was supported in part by Wellcome and the European Union’s Horizon 2020 research and innovation programme.


Source article(s)

Spatiotemporal cellular map of the developing human reproductive tract

Lorenzi V. and Icoresi-Mazzeo C., et al
Nature 17 December 2025
10.1038/s41586-025-09875-2

Our latest News

discover more
Heidelberg University Hospital is a founding member of MEDI:CUS

Heidelberg University Hospital is a founding member of MEDI:CUS

MEDI:CUS is creating a shared digital infrastructure for the healthcare sector in Baden-Württemberg. As a founding member of MEDI:CUS e. V., Heidelberg University Hospital is actively contributing to its further development. Stephan Schulz-Gohritz, Chief Financial Officer of the Heidelberg and Mannheim University Hospitals Consortium, serves on the executive board of the newly founded association. Full […]

Enzymes in small beads for a more sustainable chemistry

Enzymes in small beads for a more sustainable chemistry

KIT Researchers Develop Customized Enzyme Beads for Flexible Industrial Biocatalysis Thanks to biocatalysis using enzymes, an enormous range of active pharmaceutical ingredients and other complex molecules can now be synthesized in an environmentally friendly manner. Researchers at the Karlsruhe Institute of Technology (KIT) have now developed a technology that allows enzymes to be assembled into […]

Universität Heidelberg with Top Placings in latest Shanghai Subject Ranking

Universität Heidelberg with Top Placings in latest Shanghai Subject Ranking

Clinical medicine in position 17 internationally, medical technology ranked 21 – three subjects take top place in Germany With clinical medicine and medical technology Heidelberg University is again among the best players in Medical Sciences worldwide. In the Global Ranking of Academic Subjects 2026 clinical medicine rose by one place over last year to rank […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp